Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Patients with Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma…

On February 25, 2022

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219

Related Post

Chief Technology Officer Edmond Mesrobian Joins the WWD Tech Forum

Verisign to Report Second Quarter 2022 Financial Results

ENERGIZER HOLDINGS INC. TO WEBCAST A DISCUSSION OF THIRD QUARTER FISCAL 2022 RESULTS ON AUGUST 8